[Federal Register Volume 63, Number 225 (Monday, November 23, 1998)]
[Notices]
[Page 64723]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-31269]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Dental Plaque Subcommittee of the Nonprescription Drugs Advisory 
Committee; Notice of Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting is 
open to the public.
    Name of Committee: Dental Plaque Subcommittee of the 
Nonprescription Drugs Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on December 2 and 3, 1998, 
8:30 a.m. to 5 p.m.
    Location: Advisory Committee Conference Room 1066, 5630 Fishers 
Lane, Rockville, MD.
    Contact Person: Robert L. Sherman or Stephanie A. Mason, Center for 
Drug Evaluation and Research (HFD-560), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857, 301-827-5191, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12541. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: On December 2, 1998, the subcommittee will: (1) Review the 
ingredients triclosan and the combination of triclosan and zinc 
citrate; (2) review and vote on the combination of zinc chloride, 
sodium citrate, hydrogen peroxide, and sodium lauryl sulfate; and (3) 
discuss comments on the draft subcommittee report. On December 3, 1998, 
the subcommittee will discuss comments on the draft report and adopt 
the report.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by November 25, 
1998. Oral presentations from the public will be scheduled between 
approximately 8:30 a.m. and 12 m. Time allotted for each presentation 
may be limited. Those desiring to make formal oral presentations should 
notify the contact person before November 25, 1998, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    FDA regrets that it was unable to publish this notice 15 days prior 
to the Dental Plaque Subcommittee of the Nonprescription Drugs Advisory 
Committee meeting. Because the agency believes there is some urgency to 
bring these issues to public discussion and qualified members of the 
Dental Plaque Subcommittee of the Nonprescription Drugs Advisory 
Committee were available at this time, the Commissioner concluded that 
it was in the public interest to hold this meeting even if there was 
not sufficient time for the customary 15-day public notice.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: November 16, 1998.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 98-31269 Filed 11-20-98; 8:45 am]
BILLING CODE 4160-01-F